- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
CPHD Market Currents
more »
-
May 15 Cepheid (CPHD +3.9%) gets a lift on an upgrade to Buy on valuation at UBS this morning, citing the company's solid business momentum. The firm also raises its price target raised to $45 from $44.
Comment![On the Move]
CPHD in Focus
more »
CPHD Related Articles
more »
CPHD News
more »
-
at MarketWatch.com (Apr 20, 2012)
-
at MarketWatch.com (Jan 27, 2012)
-
at CNBC.com (Jan 27, 2012)
-
at MarketWatch.com (Jan 27, 2012)
-
at MarketWatch.com (Sep 29, 2011)
CPHD Press Releases and Filings
more »
-
PR Newswire (Wed, 7:00AM)
-
PR Newswire (Apr 26, 2012)
-
PR Newswire (Apr 19, 2012)
-
PR Newswire (Apr 5, 2012)
-
PR Newswire (Mar 20, 2012)
CPHD Latest Transcript
more »
-
Thu, Apr 23, 2009Popular searches: cphd, cepheid, mrsa, laboratory, manufacturing, Beckman, reduction, genexpert, price, expect.
CPHD Cramer
more »
-
Tue, May 6, 2008
-
Wed, Mar 12, 2008
-
Mon, Mar 10, 2008
CPHD Instablog posts
more »
CPHD vs. ETF Alternatives
Company Description
Currently, there's no company description for CPHD.
